These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24072835)

  • 1. Ataxia: a diagnostic perplexity and management dilemma.
    Chaubey VK; Chhabra L; Kapila A
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe ataxia caused by amiodarone.
    Krauser DG; Segal AZ; Kligfield P
    Am J Cardiol; 2005 Nov; 96(10):1463-4. PubMed ID: 16275201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of atrial flutter with amiodarone in a premature neonate. Case report and literature review.
    Knirsch W; Kretschmar O; Vogel M; Uhlemann F; Bauersfeld U
    Adv Neonatal Care; 2007 Jun; 7(3):113-21. PubMed ID: 17844775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone as treatment for atrial tachycardias after surgery.
    Villain E
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2130-2. PubMed ID: 9272524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia caused by amiodarone in older people.
    Hindle JV; Ibrahim A; Ramaraj R
    Age Ageing; 2008 May; 37(3):347-8. PubMed ID: 18385185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports.
    Kaur P; Kaur A; Sinha A; Khaliq W; Dumic I; Singh A
    J Clin Pharmacol; 2023 Dec; 63(12):1324-1329. PubMed ID: 37571970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis].
    Aouate P; Elbaz N; Klug D; Lacotte J; Raguin D; Frank R; Lelouche D; Dubois-Randé JL; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1181-7. PubMed ID: 12611038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiodarone-induced thyrotoxicosis cured by thyroidectomy].
    Le Cosquer P; Guerin-Robardey AM; Ossart M
    Ann Fr Anesth Reanim; 1996; 15(7):1092-4. PubMed ID: 9180986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2004 May; 93(9):1173-6. PubMed ID: 15110217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous therapy with amiodarone increases the recurrence rate in successfully ablated patients with isthmus-dependent atrial flutter.
    Ventura M; Elvas L; Providência L
    Rev Port Cardiol; 2004 Oct; 23(10):1303-11. PubMed ID: 15641295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent appearance and disappearance of amiodarone-induced skin pigmentation.
    Kounis NG; Frangides C; Papadaki PJ; Zavras GM; Goudevenos J
    Clin Cardiol; 1996 Jul; 19(7):592-4. PubMed ID: 8818442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.
    Chun SH; Sager PT; Stevenson WG; Nademanee K; Middlekauff HR; Singh BN
    Am J Cardiol; 1995 Jul; 76(1):47-50. PubMed ID: 7793402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone -- waxed and waned and waxed again.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe ataxia caused by amiodarone.
    Kashyap AS; Anand KP; Kashyap S
    Am J Cardiol; 2006 May; 97(10):1550-1. PubMed ID: 16679106
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest.
    Inoue K; Saito J; Kondo T; Miki K; Sugisawa C; Tsurutani Y; Hasegawa N; Kowase S; Kakuta Y; Omura M; Nishikawa T
    Intern Med; 2018 Jan; 57(1):59-63. PubMed ID: 29033440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.
    Wolbrette D; Gonzalez M; Samii S; Banchs J; Penny-Peterson E; Naccarelli G
    Vasc Health Risk Manag; 2010 Aug; 6():517-23. PubMed ID: 20730068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.